Amicus Therapeutics, Inc.
US ˙ NasdaqGM ˙ US03152W1099
DETTE SYMBOL ER IKKE LÆNGERE AKTIVT

SecurityFOLD / Amicus Therapeutics, Inc.
InstitutionAlliancebernstein L.p.
Latest Disclosed Ownership4,316,272 shares
Latest Disclosed Value $ 61,463,713
Alliancebernstein L.p. reports 59.19% increase in ownership of FOLD / Amicus Therapeutics, Inc.

On May 15, 2026 - Alliancebernstein L.p. filed a 13F-HR form disclosing ownership of 4,316,272 shares of Amicus Therapeutics, Inc. (US:FOLD) valued at $62,413,293 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 2,711,443 shares of Amicus Therapeutics, Inc.. This represents a change in shares of 59.19% during the quarter. The current value of the position is $62,542,781 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F AMICUS THERAPEUTIC COM 03152W109 4,316,272 1,604,829 59.19 61,464 59.19 0.0199
2026-02-17 2025-12-31 13F AMICUS THERAPEUTICS COM 03152W109 2,711,443 2,349,014 648.13 38,611 1,252.36 0.0122
2025-11-14 2025-09-30 13F AMICUS THERAPEUTICS COM 03152W109 362,429 0 0.00 2,856 37.52 0.0009
2025-08-14 2025-06-30 13F AMICUS THERAPEUTICS COM 03152W109 362,429 0 0.00 2,077 -29.79 0.0007
2025-05-15 2025-03-31 13F AMICUS THERAPEUTICS COM 03152W109 362,429 0 0.00 2,957 -13.39 0.0011
2025-02-12 2024-12-31 13F AMICUS THERAPEUTICS COM 03152W109 362,429 -6,800 -1.84 3,414 -13.42 0.0012
2024-11-14 2024-09-30 13F AMICUS THERAPEUTICS COM 03152W109 369,229 25,000 7.26 3,943 15.50 0.0013
2024-08-14 2024-06-30 13F AMICUS THERAPEUTICS COM 03152W109 344,229 21,870 6.78 3,415 -10.09 0.0012
2024-05-14 2024-03-31 13F AMICUS THERAPEUTICS COM 03152W109 322,359 -17,990 -5.29 3,797 -21.37 0.0013
2024-02-14 2023-12-31 13F AMICUS THERAPEUTICS COM 03152W109 340,349 3,000 0.89 4,830 17.72 0.0019
2023-11-14 2023-09-30 13F AMICUS THERAPEUTICS COM 03152W109 337,349 -30 -0.01 4,102 -3.19 0.0017
2023-08-15 2023-06-30 13F AMICUS THERAPEUTICS COM 03152W109 337,379 21,420 6.78 4,237 20.95 0.0017
2023-05-15 2023-03-31 13F AMICUS THERAPEUTICS COM 03152W109 315,959 30 0.01 3,504 -9.18 0.0015
2023-02-15 2022-12-31 13F AMICUS THERAPEUTICS COM 03152W109 315,929 1,200 0.38 3,857 17.38 0.0017
2022-11-15 2022-09-30 13F AMICUS THERAPEUTICS COM 03152W109 314,729 -421,536 -57.25 3,286 -58.44 0.0016
2022-08-15 2022-06-30 13F AMICUS THERAPEUTICS COM 03152W109 736,265 54,420 7.98 7,907 22.46 0.0036
2022-05-13 2022-03-31 13F AMICUS THERAPEUTICS COM 03152W109 681,845 -39,380 -5.46 6,457 -22.48 0.0025
2022-02-14 2021-12-31 13F AMICUS THERAPEUTICS COM 03152W109 721,225 -17,423 -2.36 8,330 18.09 0.0029
2021-11-10 2021-09-30 13F AMICUS THERAPEUTICS COM 03152W109 738,648 359,248 94.69 7,054 92.89 0.0028
2021-07-30 2021-06-30 13F AMICUS THERAPEUTICS COM 03152W109 379,400 -3,700 -0.97 3,657 -3.38 0.0015
2021-05-06 2021-03-31 13F AMICUS THERAPEUTICS COM 03152W109 383,100 -141,266 -26.94 3,785 -68.74 0.0017
2021-02-08 2020-12-31 13F AMICUS THERAPEUTICS COM 03152W109 524,366 0 0.00 12,108 63.53 0.0057
2020-11-12 2020-09-30 13F AMICUS THERAPEUTICS COM 03152W109 524,366 -60,470 -10.34 7,404 -16.04 0.0040
2020-08-13 2020-06-30 13F AMICUS THERAPEUTICS COM 03152W109 584,836 226,800 63.35 8,819 166.60 0.0052
2020-05-14 2020-03-31 13F AMICUS THERAPEUTICS COM 03152W109 358,036 -173,467 -32.64 3,308 -36.10 0.0024
2020-02-18 2019-12-31 13F AMICUS THERAPEUTICS COM 03152W109 531,503 211,367 66.02 5,177 101.68 0.0029
2019-11-14 2019-09-30 13F AMICUS THERAPEUTICS COM 03152W109 320,136 0 0.00 2,567 -35.74 0.0016
2019-08-14 2019-06-30 13F AMICUS THERAPEUTICS COM 03152W109 320,136 51,300 19.08 3,995 9.27 0.0025
2019-05-14 2019-03-31 13F AMICUS THERAPEUTICS COM 03152W109 268,836 -246,000 -47.78 3,656 -25.87 0.0024
2019-02-13 2018-12-31 13F AMICUS THERAPEUTICS COM 03152W109 514,836 248,500 93.30 4,932 53.17 0.0037
2018-11-08 2018-09-30 13F AMICUS THERAPEUTICS COM 03152W109 266,336 0 0.00 3,220 -22.60 0.0021
2018-08-13 2018-06-30 13F AMICUS THERAPEUTICS COM 03152W109 266,336 46,200 20.99 4,160 25.64 0.0029
2018-05-14 2018-03-31 13F AMICUS THERAPEUTICS COM 03152W109 220,136 -36,710 -14.29 3,311 -10.42 0.0024
2018-02-13 2017-12-31 13F AMICUS THERAPEUTICS COM 03152W109 256,846 -80,980 -23.97 3,696 -27.44 0.0026
2017-11-13 2017-09-30 13F AMICUS THERAPEUTICS COM 03152W109 337,826 131,990 64.12 5,094 145.73 0.0038
2017-08-10 2017-06-30 13F AMICUS THERAPEUTICS COM 03152W109 205,836 28,800 16.27 2,073 64.26 0.0016
2017-05-11 2017-03-31 13F AMICUS THERAPEUTICS COM 03152W109 177,036 -1,627,186 -90.19 1,262 -85.93 0.0010
2017-02-13 2016-12-31 13F AMICUS THERAPEUTICS COM 03152W109 1,804,222 -40,307 -2.19 8,967 -34.31 0.0075
2016-11-10 2016-09-30 13F AMICUS THERAPEUTICS COM 03152W109 1,844,529 -257,713 -12.26 13,650 18.92 0.0115
2016-08-11 2016-06-30 13F AMICUS THERAPEUTICS COM 03152W109 2,102,242 324,091 18.23 11,478 -23.61 0.0099
2016-05-13 2016-03-31 13F AMICUS THERAPEUTICS COM 03152W109 1,778,151 -414,823 -18.92 15,025 -29.37 0.0128
2016-02-16 2015-12-31 13F/A-1 AMICUS THERAPEUTICS COM 03152W109 2,192,974 212,897 10.75 21,272 -23.21 0.0181
2016-02-12 2015-12-31 13F AMICUS THERAPEUTICS COM 03152W109 2,192,974 30,680
2015-11-13 2015-09-30 13F AMICUS THERAPEUTICS COM 03152W109 1,980,077 1,822,277 1,154.80 27,701 1,140.53 0.0238
2015-08-14 2015-06-30 13F AMICUS THERAPEUTICS COM 03152W109 157,800 154,100 4,164.86 2,233 5,482.50 0.0018
2015-05-13 2015-03-31 13F AMICUS THERAPEUTICS COM 03152W109 3,700 0 0.00 40 29.03 0.0000
2015-02-13 2014-12-31 13F AMICUS THERAPEUTICS COM 03152W109 3,700 -74,865 -95.29 31 -80.98 0.0000
2014-05-13 2014-03-31 13F AMICUS THERAPEUTICS COM 03152W109 78,565 -3,700 -4.50 163 -15.54 0.0001
2014-02-13 2013-12-31 13F AMICUS THERAPEUTICS COM 03152W109 82,265 -13,400 -14.01 193 -13.06 0.0002
2013-11-14 2013-09-30 13F AMICUS THERAPEUTICS COM 03152W109 95,665 -1,526 -1.57 222 -1.77 0.0002
2013-08-13 2013-06-30 13F AMICUS THERAPEUTICS COM 03152W109 97,191 97,191 226 0.0002
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.